Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.

about

IL-1α correlates with severity of hepatitis C virus-related liver diseases.Copeptin as a novel marker predicting prognosis of liver cirrhosis and its major complications

P2860

Q55717409-C97DF421-9877-442F-931D-10034240344A Q58765012-2392008A-B60A-4A6B-91E5-6D06D348C2E9

P2860

Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.

Item

http://www.wikidata.org/entity/Q53837635

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@en

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@nl

type

Item

label

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@en

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@nl

prefLabel

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@en

Efficacy and safety of sofosbu ...... atitis C genotype 4 infection.

@nl

P1476

Efficacy and safety of sofosbu ...... patitis C genotype 4 infection

@en

P2093

Hany H Kaisar

http://www.w3.org/2001/XMLSchema#string

Hossam Samir

http://www.w3.org/2001/XMLSchema#string

Nehad Hawash

http://www.w3.org/2001/XMLSchema#string

Ossama A Ahmed

http://www.w3.org/2001/XMLSchema#string

Rehab Badawi

http://www.w3.org/2001/XMLSchema#string

Samy A Khodeir

http://www.w3.org/2001/XMLSchema#string

Sherif St Shabana

http://www.w3.org/2001/XMLSchema#string

P2860

Ledipasvir and sofosbuvir for untreated HCV genotype 1 infection

Ledipasvir and sofosbuvir for 8 or 12 weeks for chronic HCV without cirrhosis

Ledipasvir and sofosbuvir for previously treated HCV genotype 1 infection

The risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical Registry.

Prior to the oral therapy, what do we know about HCV-4 in Egypt: a randomized survey of prevalence and risks using data mining computed analysis.

Safety and efficacy of ledipasvir-sofosbuvir in black patients with hepatitis C virus infection: A retrospective analysis of phase 3 data.

Sofosbuvir and ledipasvir fixed-dose combination with and without ribavirin in treatment-naive and previously treated patients with genotype 1 hepatitis C virus infection (LONESTAR): an open-label, randomised, phase 2 trial.

Hepatitis C guidance: AASLD-IDSA recommendations for testing, managing, and treating adults infected with hepatitis C virus.

Ledipasvir and sofosbuvir for hepatitis C genotype 4: a proof-of-concept, single-centre, open-label phase 2a cohort study.

Review article: the epidemiology and therapy of chronic hepatitis C genotypes 4, 5 and 6.

P304

295-298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2147/IDR.S153060

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

http://www.w3.org/2001/XMLSchema#string

P50

Sherief Abd-Elsalam

Mohamed Hassan A Fouad

Fatma H Rizk

P577

2018-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29535545

http://www.w3.org/2001/XMLSchema#string

P921

sofosbuvir

P932

5840188

http://www.w3.org/2001/XMLSchema#string

Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.

about

P2860

P2860

Efficacy and safety of sofosbuvir-ledipasvir for treatment of a cohort of Egyptian patients with chronic hepatitis C genotype 4 infection.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P478

P50

P577

P698

P921

P932